From the bench to the field in low-cost diagnostics: Two case studies

Angewandte Chemie - International Edition

Volumn 54, Issue 20, 2015, Pages 5836-5853

  Kumar, Ashok A ^a   Hennek, Jonathan W ^a   Smith, Barbara S ^a   Kumar, Shailendra ^b   Beattie, Patrick ^b   Jain, Sidhartha ^b   Rolland, Jason P ^b   Stossel, Thomas P ^c   Chunda Liyoka, Catherine ^d   Whitesides, George M ^a,e  

^a HARVARD UNIVERSITY   (United States)

^b Diagnostics for All   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY TEACHING HOSPITAL   (Zambia)

^e HARVARD UNIVERSITY   (United States)

Author keywords

field trials; liver injury; point of care diagnostics; sickle cell disease; technologytranslation

Indexed keywords

DEVELOPING COUNTRIES;

FIELD TRIAL; LIVER INJURIES; POINT OF CARE DIAGNOSTIC; SICKLE CELL DISEASE; TECHNOLOGYTRANSLATION;

DIAGNOSIS;

ANEMIA, SICKLE CELL; ECONOMICS; HOSPITAL INFORMATION SYSTEM; HUMAN; LIVER FUNCTION TEST;

ANEMIA, SICKLE CELL; HUMANS; LIVER FUNCTION TESTS; POINT-OF-CARE SYSTEMS;

EID: 84928892855     PISSN: 14337851     EISSN: 15213773     Source Type: Journal    
DOI: 10.1002/anie.201411741     Document Type: Article

References (55)

1. P. Yager, G. J. Domingo, J. Gerdes, Annu. Rev. Biomed. Eng. 2008, 10, 107-144.
2. S. K. Sia, L. J. Kricka, Lab Chip 2008, 8, 1982-1983.
3. C. D. Chin, V. Linder, S. K. Sia, Lab Chip 2007, 7, 41-57.
4. C. D. Chin, V. Linder, S. K. Sia, Lab Chip 2012, 12, 2118-2134.
5. G. Whitesides, Lab Chip 2014, 14, 3125-3126.
6. D. A. Pitta, R. Guesalaga, P. Marshall, J. Consum. Mark. 2008, 25, 393-401.
7. A. W. Martinez, S. T. Phillips, M. J. Butte, G. M. Whitesides, Angew. Chem. Int. Ed. 2007, 46, 1318-1320
8. Angew. Chem. 2007, 119, 1340-1342.
9. N. R. Pollock, J. P. Rolland, S. Kumar, P. D. Beattie, S. Jain, F. Noubary, V. L. Wong, R. A. Pohlmann, U. S. Ryan, G. M. Whitesides, Sci. Transl. Med. 2012, 4, 152ra 129.
10. S. J. Vella, P. Beattie, R. Cademartiri, A. Laromaine, A. W. Martinez, S. T. Phillips, K. A. Mirica, G. M. Whitesides, Anal. Chem. 2012, 84, 2883-2891.
11. N. R. Pollock, S. McGray, D. J. Colby, F. Noubary, H. Nguyen, T. A. Nguyen, S. Khormaee, S. Jain, K. Hawkins, S. Kumar, J. P. Roland, P. D. Beattie, N. V. Chau, V. M. Quang, C. Barfield, K. Tietje, M. Steele, B. H. Weigl, PLoS One 2013, 8, e 75616.
12. C. R. Mace, O. Akbulut, A. A. Kumar, N. D. Shapiro, R. Derda, M. R. Patton, G. M. Whitesides, J. Am. Chem. Soc. 2012, 134, 9094-9097.
13. A. A. Kumar, M. R. Patton, J. W. Hennek, S. Y. R. Lee, G. D'Alesio-Spina, X. Yang, J. Kanter, S. S. Shevkoplyas, C. Brugnara, G. M. Whitesides, Proc. Natl. Acad. Sci. USA 2014, 111, 14864-14869.
14. A. A. Kumar, C. Chunda-Liyoka, J. W. Hennek, H. Mantina, S. Y. R. Lee, M. R. Patton, P. Sambo, S. Sinyangwe, C. Kankasa, C. Chintu, C. Brugnara, T. P. Stossel, G. M. Whitesides, PLoS One 2014, 9, e 114540.
15. R. W. Peeling, D. Mabey, Clin. Microbiol. Infect. 2010, 16, 1062-1069.
16. D. Mabey, R. W. Peeling, A. Ustianowski, M. D. Perkins, Nat. Rev. Microbiol. 2004, 2, 231-240.
17. This criterion may be less important in cases where incentives are created, either by government initiatives or nonprofit organizations working to promote research on niche diseases. For example, the Food and Drug Administration (FDA) in the US has promoted research on orphan diseases through various incentives (http://www.fda.gov/forindustry/DevelopingProductsforrareDiseasesConditions/default.htm).
18. H. Kettler, K. White, S. Hawkes, Mapping the Landscape of Diagnostics for Sexually Transmitted Infections: Key Findings and Recommendations, 2004, Available at: http://www.who.int/tdr/publications/documents/mapping-landscape-sti.pdf.
19. eMarketer Inc., "Smartphone Users Worldwide Will Total 1.75 Billion in 2014," can be found under http://www.emarketer.com/Article/Smartphone-UsersWorldwide-Will-Total-175-Billion-2014/1010536, 2014.
20. N. P. Pai, C. Vadnais, C. Denkinger, N. Engel, M. Pai, PLoS Med. 2012, 9, e 1001306.
21. B. H. Weigl, D. S. Boyle, T. de Los Santos, R. B. Peck, M. S. Steele, Expert Rev. Med. Devices 2009, 6, 461-464.
22. J. Colyvas, M. Crow, A. Gelijns, R. Mazzoleni, R. R. Nelson, N. Rosenberg, B. N. Sampat, Manage. Sci. 2002, 48, 61-72.
23. D. Somaya, J. Manage. 2012, 38, 1084-1114.
24. D. Guellec, C. Martinez, P. Zuniga, Econ. Innovation New Tech. 2012, 21, 1-29.
25. B. A. Caldwell, A. Young, J. Gomez-Marquez, K. R. Olson, IEEE Pulse 2011, 2, 63-67.
26. C. VanVoorhis, B. Morgan, Tutor. Quant. Methods Psychol. 2007, 3, 43-50.
27. G. Cumming, F. Fidler, D. L. Vaux, J. Cell Biol. 2007, 177, 7-11.
28. D. L. Vaux, Nature 2012, 492, 180-181.
29. National Committee for Clinical Laboratory Standards, Procedures and Devices for the Collection of Diagnostic Capillary Blood Specimens (Approved Standard HA-A5), NCCLS, Wayne, PA, 2004.
30. C. E. Metz, Semin. Nucl. Med. 1978, 8, 283-298.
31. J. M. Bland, D. G. Altman, Stat. Methods Med. Res. 1999, 8, 135-160.
32. S. J. Pocock, L. M. Friedman, C. D. Furberg, D. L. Demets, Fundamentals of Clinical Trials, Springer, New York, 2010.
33. R. Glasgow, D. Magid, A. Beck, Med. Care 2005, 43, 551-557.
34. J. Lachin, Control. Clin. Trials 1981, 2, 93-113.
35. K. S. Button, J. P. A. Ioannidis, C. Mokrysz, B. A. Nosek, J. Flint, E. S. J. Robinson, M. R. Munafò, Nat. Rev. Neurosci. 2013, 14, 365-376.
36. United Nations, Political Declaration on HIV and AIDS: Intensifying Our Efforts to Eliminate HIV and AIDS, 2011, Available at: http://www.unaids.org/sites/default/files/sub-landing/files/20110610-UN-A-RES-65-277-en.pdf.
37. E. Martínez, J. L. Blanco, J. A. Arnaiz, J. B. Pérez-Cuevas, A. Mocroft, A. Cruceta, M. A. Marcos, A. Milinkovic, M. A. García-Viejo, J. Mallolas, X. Carne, A. Phillips, J. M. Gatell, AIDS 2001, 15, 1261-1268.
38. Panel on Antiretroviral Guidelines for Adults and Adolescents., Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. 2009, Available at: http://aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf.
39. G. Meintjes, G. Maartens, A. Boulle, F. Conradie, E. Goemaere, E. Hefer, D. Johnson, M. Mathe, Y. Moosa, R. Osih, T. Rossouw, G. van Cutsem, E. Variava, F. Venter, D. Spencer, South. Afr. J. HIV Med. 2012, 13, 114-133.
40. Current Medical Diagnostics and Treatment (Eds.:, S. J. McPhee, M. A. Papadakis,), McGraw Hill, New York, 2010.
41. A. W. Martinez, S. T. Phillips, G. M. Whitesides, E. Carrilho, Anal. Chem. 2010, 82, 3-10.
42. A. W. Martinez, S. T. Phillips, E. Carrilho, S. W. Thomas, H. Sindi, G. M. Whitesides, Anal. Chem. 2008, 80, 3699-3707.
43. A. W. Martinez, S. T. Phillips, G. M. Whitesides, Proc. Natl. Acad. Sci. USA 2008, 105, 19606-19611.
44. C. D. Chin, T. Laksanasopin, Y. K. Cheung, D. Steinmiller, V. Linder, H. Parsa, J. Wang, H. Moore, R. Rouse, G. Umviligihozo, E. Karita, L. Mwambarangwe, S. L. Braunstein, J. van de Wijgert, R. Sahabo, J. E. Justman, W. El-Sadr, S. K. Sia, Nat. Med. 2011, 17, 1015-1019.
45. F. B. Piel, S. I. Hay, S. Gupta, D. J. Weatherall, T. N. Williams, PLoS Med. 2013, 10, e 1001484.
46. J. Hankins, R. E. Ware, Lancet 2009, 374, 1308-1310.
47. M. Gaston, J. Verter, G. Woods, C. Pegelow, J. Kelleher, G. Presbury, H. Zarkowsky, E. Vichinsky, R. Iyer, J. Lobel, S. Diamond, C. T. Holbrook, F. M. Gill, K. Ritchey, J. M. Falletta, N. Engl. J. Med. 1986, 314, 1593-1599.
48. M. E. Fabry, J. G. Mears, P. Patel, K. Schaefer-Rego, L. D. Carmichael, G. Martinez, R. L. Nagel, Blood 1984, 64, 1042-1046.
49. S. Embury, M. Clark, J. Clin. Invest. 1984, 73, 116-123.
50. W. H. Grover, A. K. Bryan, M. Diez-Silva, S. Suresh, J. M. Higgins, S. R. Manalis, Proc. Natl. Acad. Sci. USA 2011, 108, 10992-10996.
51. H. B. Weems, L. S. Lessin, Acta Haematol. 1984, 71, 361-370.
52. A. A. Kumar, C. Lim, Y. Moreno, C. R. Mace, A. Syed, D. Van Tyne, D. F. Wirth, M. T. Duraisingh, G. M. Whitesides, Am. J. Hematol. 2015, 90, 31-36.
53. C. Brugnara, T. Van Ha, D. C. Tosteson, Blood 1989, 74, 487-495.
54. C. Brugnara, J. Pediatr. Hematol. Oncol. 2003, 25, 927-933.
55. A. Kratz, M. Ferraro, P. M. Sluss, K. B. Lewandrowski, N. Engl. J. Med. 2004, 351, 1548-1564.